Gland Pharma said that it has received approval from the United States Food and Drug Administration (US FDA) for its abbreviated new drug application (ANDA) for Angiotensin II Acetate Injection.

Bayer said it received approval from the Food and Drug Administration for its drug Nubeqa, which treats patients with a certain type of prostate cancer.

The FDA rolled out a generative AI tool for speeding regulatory reviews, announcing its launch nearly a month ahead of a June ...

Drug-induced liver injury cases are increasing, with common medications and supplements posing hidden dangers, especially for ...

Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, ...

Some of these “risky” foods include products from major brands like McDonald’s and Boar’s Head, as well as some potentially ...

Federal health officials have changed the game for COVID vaccine access. Pregnant moms and others who rely on them to protect ...

New research suggests that removing fluoride from public water would increase dental care costs and tooth decay for children ...

The Trump administration has moved to end funding for a broad swath of HIV vaccine research, saying current approaches are ...

A tomato recall initiated in early May has now been classified by the Food and Drug Administration (FDA) as Class I — the agency’s highest level.

Creon, a pancreatic enzyme replacement therapy, helps patients with pancreatic cancer and cystic fibrosis digest food. Its ...

Bi Jingquan, former head of the now-defunct China Food and Drug Administration (CFDA), is being investigated for suspected ...